← Back to Search

ECG Technology

Holter Device for Fetal Monitoring

N/A
Recruiting
Led By Martin G Frasch, MD, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test a new way to measure fetal heart activity, to see if it is as accurate as the current standard.

Who is the study for?
This clinical trial is open to pregnant women carrying one or two babies, who are between 32 weeks gestation and full term. They should be after their routine antepartum testing with no specific exclusions mentioned.Check my eligibility
What is being tested?
The study is testing if a Holter ECG device, typically used for heart monitoring, can also capture the heartbeat of an unborn baby. It will be compared to the standard Doppler Fetal Heart Rate monitor that's commonly used during pregnancy.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring with a Holter device and standard Doppler FHR device, there are no direct side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Successful extraction of fetal ECG from the maternal abdominal ECG signal

Trial Design

1Treatment groups
Experimental Treatment
Group I: Holter deviceExperimental Treatment1 Intervention
Holter device to be attached to a Singleton or twin pregnant women at 32 weeks gestation to full term

Find a Location

Who is running the clinical trial?

Duke UniversityOTHER
2,363 Previous Clinical Trials
3,420,459 Total Patients Enrolled
University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,620 Total Patients Enrolled
Martin G Frasch, MD, PhDPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
11 Total Patients Enrolled

Media Library

Holter Device (ECG Technology) Clinical Trial Eligibility Overview. Trial Name: NCT03111173 — N/A
Fetal Monitoring Research Study Groups: Holter device
Fetal Monitoring Clinical Trial 2023: Holter Device Highlights & Side Effects. Trial Name: NCT03111173 — N/A
Holter Device (ECG Technology) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03111173 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity to enroll in this clinical experiment?

"Correct. The public information on clinicaltrials.gov indicates that this medical trial, which went live on June 2nd 2017, is currently recruiting subjects. This study aims to enrol 50 individuals from 1 site."

Answered by AI

Are people under the age of sixty eligible to participate in this trial?

"As per the eligibility requirements, individuals between 18 and 55 years old are invited to participate in this medical research."

Answered by AI

What is the total sample size of this research endeavor?

"Affirmative. Clinicaltrials.gov details that this medical experiment, which was published on June 2nd 2017, is actively recruiting patients presently. 50 individuals must be recruited from 1 trial site for the research to progress."

Answered by AI

Is there any way I can participate in this medical research?

"Qualified candidates must have fetal monitoring and be between 18-55 years old. This clinical trial is hoping to enrol a total of 50 participants."

Answered by AI
~7 spots leftby Jun 2025